Elutia announces fda clearance of elupro®: the first antibiotic-eluting bioenvelope designed to protect patients with implantable cardiac pacemakers and defibrillators

Elupro becomes the only drug-eluting biologic envelope to receive fda clearance in the $600 million u.s. implantable electronic device protection market
ELUT Ratings Summary
ELUT Quant Ranking